NYSE: USNAUsana Health Sciences Revenue
Usana Health Sciences revenue was $854.50M for the trailing 12 months ending Dec 28, 2024, with -33.5% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 28, 2024 was $213.6M, up 6.7% from last quarter. For the last reported fiscal year 2024 ending Dec 28, 2024, USNA annual revenue was $854.5M, with -7.2% growth year-over-year.
USNA past revenue growth
How has USNA's revenue growth performed historically?
Company
-7.22%
Industry
3.51%
Market
20.27%
USNA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
USNA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
USNA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
USNA revenue history
Current Revenue
$854.5M
Current Earnings
$42.0M
Current Profit Margin
4.9%
USNA's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when USNA announces revenue.
USNA Revenue History By Year
| USNA Yearly Revenue | USNA Revenue | USNA Change | USNA Revenue Growth |
|---|---|---|---|
| 2024-12-28 | $854.50M | -$66.51M | -7.22% |
| 2023-12-30 | $921.01M | -$77.59M | -7.77% |
| 2022-12-31 | $998.60M | -$187.86M | -15.83% |
| 2022-01-01 | $1.19B | $51.82M | +4.57% |
| 2021-01-02 | $1.13B | $73.74M | +6.95% |
| 2019-12-28 | $1.06B | -$128.35M | -10.79% |
| 2018-12-29 | $1.19B | $141.98M | +13.56% |
| 2017-12-30 | $1.05B | $41.18M | +4.09% |
| 2016-12-31 | $1.01B | $87.58M | +9.54% |
| 2016-01-02 | $918.50M | $128.03M | +16.20% |
| 2015-01-03 | $790.47M | $72.30M | +10.07% |
| 2013-12-28 | $718.18M | $69.45M | +10.71% |
| 2012-12-29 | $648.73M | $66.79M | +11.48% |
| 2011-12-31 | $581.94M | $64.30M | +12.42% |
| 2011-01-01 | $517.64M | $80.70M | +18.47% |
| 2010-01-02 | $436.94M | $7.93M | +1.85% |
| 2009-01-03 | $429.01M | $5.86M | +1.39% |
| 2007-12-29 | $423.15M | $57.98M | +15.88% |
| 2006-12-30 | $365.17M | $50.15M | +15.92% |
| 2005-12-31 | $315.02M | $45.67M | +16.95% |
| 2005-01-01 | $269.35M | $69.34M | +34.67% |
| 2004-01-03 | $200.01M | $66.24M | +49.51% |
| 2002-12-28 | $133.78M | $19.50M | +17.06% |
| 2001-12-29 | $114.28M | -$8.90M | -7.23% |
| 2000-12-30 | $123.18M | -$11.13M | -8.29% |
| 2000-01-01 | $134.31M | $8.02M | +6.35% |
| 1999-01-02 | $126.29M | $41.09M | +48.22% |
| 1997-12-27 | $85.21M | $28.51M | +50.27% |
| 1996-12-28 | $56.70M | $32.16M | +131.04% |
| 1995-12-31 | $24.54M | $17.22M | +235.40% |
| 1994-12-31 | $7.32M | N/A | N/A |
Usana Health Sciences Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.